Microdosed Atropine 0.1% and 0.01% Ophthalmic Solutions for Reduction of Pediatric Myopia Progression

NCT03942419 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
438
Enrollment
INDUSTRY
Sponsor class

Stopped Interim Analysis reviewed by Data Monitoring Committee indicated futility

Conditions

Interventions

Sponsor

Eyenovia Inc.